In cancer clinical trials, federal and industry sponsors play complementary roles

A comparative study of the cancer clinical trial portfolios supported by federal funding versus industry funding reveals they have distinct, interdependent roles in cancer research.The work, "Federal and Industry Sponsorship in US Cancer Clinical Trials," was published in JAMA Oncology.

Read it at Medical Xpress ↗

← Front page